Phillips 66 Other Income (Expense) increased by 60.6% to $204.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 264.3%, from $56.00M to $204.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a -0.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $238.00M | $150.00M | -$143.00M | -$185.00M | $3.03B | $39.00M | $48.00M | $99.00M | $15.00M | $197.00M | $97.00M | $58.00M | $84.00M | $4.00M | $56.00M | $139.00M | $116.00M | $127.00M | $204.00M |
| QoQ Change | — | +366.7% | -37.0% | -195.3% | -29.4% | >999% | -98.7% | +23.1% | +106.3% | -84.8% | >999% | -50.8% | -40.2% | +44.8% | -95.2% | >999% | +148.2% | -16.5% | +9.5% | +60.6% |
| YoY Change | — | — | — | — | -462.7% | >999% | -74.0% | +133.6% | +153.5% | -99.5% | +405.1% | +102.1% | -41.4% | +460.0% | -98.0% | -42.3% | +139.7% | +38.1% | >999% | +264.3% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Renewable Fuels | — | — | — | $19.00M | $44.00M | $53.00M | $88.00M | $74.00M |
| Refining | — | — | — | $3.00M | $34.00M | $1.00M | $2.00M | $26.00M |
| Midstream | — | — | — | $10.00M | $3.00M | $20.00M | $0.00 | $19.00M |
| Chemicals | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| M&S | — | — | — | $6.00M | — | — | — | — |
| Marketing and Specialties | -$750.00K | -$750.00K | -$750.00K | -$500.00K | -$500.00K | -$500.00K | -$500.00K | — |
| Total | $58.00M | $84.00M | $4.00M | $56.00M | $139.00M | $116.00M | $127.00M | $204.00M |
Marketing and Specialties is derived from annual filings.